Abiopharma

ARCH CAPITAL GROUP LTD. (ACGL) Reports the reporting period Financial Results ARCH CAPITAL GROUP LTD. (ACGL) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: $2,645
• Net Income: 564
• EPS: $6,425
• Cash and equivalents: $87 million
  • anticipated by the Company;•the Company’s investment performance, including legislative or regulatory developments that may adversely affect the fair value of the Company’s investments;11•changes in general economic conditions, resulting in downgrades of U.S. securities or sovereign debt by credit rating agencies, which could affect the Company’s business, financial condition and results of operations;•an incident, disruption in operations or other cyber event caused by cyber attacks, the use of artificial intelligence technologies or other technology on the Company’s systems or those of the Company’s business partners and service providers, which could negatively impact the Company’s business and/or expose the Company to litigation; •the effect of climate change on the Company’s business;•the effect of contagious diseases or a pandemic on the Company’s business;•acts of terrorism, political unrest and other hostilities or other unforecasted and unpredictable events caused by humans; •the volatility of the Company’s shareholders’ equity from foreign currency fluctuations, which could increase due to us not matching portions of the Company’s projected liabilities in foreign currencies with investments in the same currencies; •changes in accounting principles or policies or in the Company’s application of such accounting principles or policies;•changes in the political environment of certain countries in which the Company operate or underwrite business;•statutory or regulatory developments, including as to tax matters and insurance and other regulatory matters such as the adoption of legislation that affects Bermuda-headquartered companies and/or Bermuda-based insurers or reinsurers and/or changes in regulations or tax laws applicable to the Company, its subsidiaries, brokers or customers, including the implementation of the Organization for Economic Cooperation and Development (“OECD”) Pillar I and Pillar II initiative and the enactment of the Bermuda corporate income tax; and•the other matters set forth under Item 1A “Risk Factors”, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other sections of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025